WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 動脈瘤性くも膜下出血の治療 treatment of aneurysmal subarachnoid hemorrhage
2. 可逆性脳血管攣縮症候群 reversible cerebral vasoconstriction syndromes
3. 動脈瘤性くも膜下出血の臨床症状および診断 clinical manifestations and diagnosis of aneurysmal subarachnoid hemorrhage
4. 頭蓋内大血管の動脈硬化 intracranial large artery atherosclerosis
5. 非動脈瘤性くも膜下出血 nonaneurysmal subarachnoid hemorrhage

Does Mechanical Thrombectomy in Acute Embolic Stroke Have Long-term Side Effects on Intracranial Vessels? An Angiographic Follow-up Study.

Kurre W, Pérez MA, Horvath D, Schmid E, Bäzner H, Henkes H.SourceKlinik für Diagnostische und Interventionelle Neuroradiologie, Klinikum Stuttgart, Kriegsbergstrasse 60, 70174, Stuttgart, Germany, w.kurre@klinikum-stuttgart.de.
Cardiovascular and interventional radiology.Cardiovasc Intervent Radiol.2013 Jun;36(3):629-36. doi: 10.1007/s00270-012-0496-8. Epub 2012 Oct 20.
PURPOSE: Mechanical thrombectomy (mTE) proved to be effective treating acute vessel occlusions with an acceptable rate of procedural complications. Potential long-term side effects of the vessel wall trauma caused by mechanical irritation of the endothelium are unknown up to now.METHODS: From a retr
PMID 23086452

Delayed retraction of the pipeline embolization device and corking failure: pitfalls of pipeline embolization device placement in the setting of a ruptured aneurysm.

McTaggart RA, Santarelli JG, Marcellus ML, Steinberg GK, Dodd RL, Do HM, Marks MP.SourceDepartments of *Radiology and ‡Neurosurgery, Stanford University School of Medicine, Stanford, California.
Neurosurgery.Neurosurgery.2013 Jun;72(2 Suppl Operative):onsE245-51. doi: 10.1227/NEU.0b013e31827fc9be.
BACKGROUND AND IMPORTANCE: : The safety of flow-diverting stents for the treatment of ruptured intracranial aneurysms is unknown.CLINICAL PRESENTATION: : A 35-year-old woman with a ruptured dissecting aneurysm of the intradural right vertebral artery and incorporating the right posterior inferior ce
PMID 23190640

[The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage].

Murahashi T, Kamiyama K, Hara K, Ozaki M, Mikamoto M, Nakagaki Y, Nakagaki Y, Nakamura H.SourceDepartment of Neurosurgery, Nakamura Memorial Hospital.
No shinkei geka. Neurological surgery.No Shinkei Geka.2013 May;41(5):393-400.
Delayed ischemic deficit following subarachnoid hemorrhage(SAH)is a major source of morbidity and mortality after rupture of an intracranial aneurysm. Once symptomatic cerebral vasospasm has occured, available treatments do not provide good outcomes for all patients. Symptomatic vasospasm results in
PMID 23648655

齋藤倫子,永井玲恩,並木みずほ [他],阿部勝,原田知幸,武田宗和,宇都健太,小田秀明,平井由児,矢口有乃
東京女子医科大学雑誌 85(1), 16-21, 2015-02-25
42歳女性。中耳炎の診断で通院中に意識障害を呈し前医に搬送され、肺炎球菌性髄膜炎の診断に至った。脳ヘルニアを認めたことから当院ICUに転院となり、ceftriaxone sodium hydrate(CTRX)、vancomycin hydrochloride(VCM) 投与開始し、水頭症に対しドレナージ施行した。髄液培養からムコイド型株のStreptococcus pneumoniaeが検出され …
NAID 110009883331

鈴木秀謙,川北文博,刘磊,市川尚己,藤本昌志,芝真人
脳神経外科ジャーナル 24(4), 232-238, 2015
脳動脈瘤破裂によるくも膜下出血 (SAH) は依然, 予後不良である. 脳血管攣縮は介入可能な予後不良因子として最重要視され, 過去50年以上にわたり研究および治療のターゲットであった. しかし, 遅発性脳梗塞の発生率はいまだに約20%と高く, 解決したとは言い難い. 一方, 最近の臨床研究で脳血管攣縮の克服だけではSAHの予後改善に限界があることは明らかである. 即ち, 脳血管攣縮とは別に脳側 …
NAID 130005066022

Current Status of Endovascular Treatment for Vasospasm following Subarachnoid Hemorrhage: Analysis of JR-NET2

Hayashi Kentaro,Hirao Tomohito,Sakai Nobuyuki,Nagata Izumi
Neurologia medico-chirurgica 54(2), 107-112, 2014-02-15
… Endovascular treatments are employed for cerebral vasospasm following subarachnoid hemorrhage, which is not responded to the medical treatments. … Here, we analyzed the data of Japanese Registry of Neuroendovascular Therapy 2 (JR-NET2) and revealed current status of the endovascular treatment for the cerebral vasospasm. … The timing of the endovascular treatment for the cerebral vasospasm was within 3 hours in 209 cases, 3-6 hours in 158 cases, and more than 6 hours in 158 cases. …
NAID 120005438853